Rikhav Securities Ltd IPO

Last Updated: 17 January 2025 6:35 PM by 5Paisa

Suraksha Diagnostic, is a prominent provider of pathology, radiology, and medical consultancy services. With a robust infrastructure comprising a central reference laboratory, eight satellite labs, and 215 customer touchpoints—including 49 diagnostic centers and 166 sample collection facilities—the company operates across West Bengal, Bihar, Assam, and Meghalaya. Its 44 diagnostic centers also house 120 polyclinics with over 750 doctors, offering both online and offline medical consultations. Leveraging advanced systems like Laboratory Information Management System (LIMS), Radiology Information System (RIS), Picture Archive Communication System (PACS), and Enterprise Resource Planning (ERP), Suraksha ensures streamlined operations and reduced turnaround times.

The company specializes in vaccination services and customized testing packages for early disease detection, utilizing digital pathology and AI-driven blood test generation. Suraksha’s competitive edge lies in its integrated service model, advanced clinical infrastructure, and a strong focus on quality, ensuring high customer retention in fragmented eastern and northeastern Indian markets.

Objectives

The IPO proceeds will not be utilized for the company’s operations or growth plans. Instead, the purpose of the IPO is to enable existing shareholders to divest their holdings and exit the business.